Indian Billionaire Gautam Adani Comes Under New Scrutiny from U.S. Prosecutors
Gautam Adani, Asia's second-richest man, is trying to get the Trump administration to drop foreign bribery charges against him. Instead, he is facing a new front in his fight with prosecutors: a probe into whether his companies are buying Iranian petrochemical products.
U.S. prosecutors are investigating whether Adani's companies imported Iranian liquefied petroleum gas, or LPG, into India through the company's Mundra port. A Wall Street Journal investigation into tankers that regularly traveled between Mundra and the Persian Gulf found their behavior often exhibited traits seen by ships seeking to evade sanctions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Natural Capsules Ltd (BOM:524654) Q4 2025 Earnings Call Highlights: Navigating Challenges and ...
Release Date: June 04, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Natural Capsules Ltd (BOM:524654) reported a revenue growth of 2.61% quarter-on-quarter and 11.8% year-on-year for Q4 FY25. The company anticipates improved profitability due to the softening of gelatin prices in the international market. The imposition of an 88% duty by the US on Chinese HPMC capsules compared to a 14% duty on Indian HPMC capsules opens up significant opportunities for Indian manufacturers. Natural Capsules Ltd has secured firm orders in the HPMC business, providing strong visibility for improved performance. The company expects top-line growth to be driven by HPMC capsules, which command higher realization and superior profitability. Profit after tax for Q4 FY25 decreased by 46.32% compared to Q4 FY24. For the full year FY25, profit after tax decreased by 88.88% compared to FY24. The API segment faces challenges with industry-wide pressure on product realization due to significant excess capacity in China. The company has experienced delays in the start of the PLI scheme due to issues with the pollution control board. Natural Capsules Ltd has been missing targets and guidance quarter-on-quarter, leading to concerns about execution consistency. Warning! GuruFocus has detected 7 Warning Signs with BOM:524654. Q: What is the expected top-line revenue from the API facility in its first year of operation, and what PLI benefits are anticipated? A: The expected top-line revenue from the API business in the first year is about 65 crores, with anticipated PLI benefits of approximately 9 crores. The company has addressed delays with the authorities, and the Department of Pharmaceuticals is evaluating the situation. - Mr. Sunil Mundra, Managing Director Q: Can you elaborate on the impact of US tariffs on Chinese HPMC capsules and the strategy for the HPMC line segment? A: The US has imposed an 88% duty on Chinese HPMC capsules, compared to 14% on Indian capsules, creating a competitive advantage for us. We expect to scale up our HPMC business in the US, with anticipated revenue growth from 9 crores to 27 crores in FY26. - Mr. Sunil Mundra, Managing Director Q: What are the operational improvements implemented to ensure consistent quality and yield in the API segment? A: We have introduced standard operating procedures in manufacturing batches to ensure consistent quality and yield. Continuous monitoring and R&D efforts are in place to improve yields to industry standards. - Mr. Sunil Mundra, Managing Director Q: How does the company plan to address the challenges in the API segment, given the current market conditions? A: The API segment faces challenges due to excess capacity in China and declining prices. We are focusing on ramping up capacity utilization and securing regulatory approvals to improve operational performance. - Mr. Sunil Mundra, Managing Director Q: What is the company's strategy for growth in the capsule business, and how will it impact profitability? A: The focus is on regulated markets and value-added products to drive growth and restore profitability. We anticipate an 8-10% growth in the capsule business, with improved margins due to strategic marketing and product composition changes. - Mr. Sunil Mundra, Managing Director For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
England bring Woakes, Carse and Overton into squad for first India Test
There is still a fortnight to go until the first Test against India but England are a team in a hurry these days. On Thursday morning they named a 14-man squad for the series opener, with Brydon Carse, Chris Woakes, and Jamie Overton all drafted in as options with the ball after Gus Atkinson was ruled out through injury. No official date has been put on Atkinson's return after a hamstring issue picked up during the innings victory against Zimbabwe last month. But with a week between the first Test at Headingley that starts on 20 June and the second at Lord's, England are hopeful that the breakout star of last year can have an impact on the five-match series. Advertisement Related: 'It's Harry's team now': Brook makes instant impact in new England era In the meantime, five seamers are likely to compete for three spots in the XI, with Josh Tongue and Sam Cook retained after the one-off Test against Zimbabwe and the unused Matthew Potts now overlooked altogether. Cook, who took one for 119 on debut, will be hoping for a second chance to impress with the new ball. This may hinge on whether Woakes is up to speed, with the 36-year-old's start to the summer delayed by a bone stress reaction in his ankle. Having played one round of county cricket for Warwickshire a fortnight ago, the next fitness test comes with an outing for England Lions against India A starting on Friday. Tongue will similarly feature in this match, making the early release of the Test squad a surprise. The same can be said for Overton's recall, three years after his solitary Test cap against New Zealand and now nursing a broken little finger. Although with Atkinson missing, and Woakes still to prove his readiness, the long-handle with which Overton plundered 97 on debut could shore up the lower order. Carse, back after a toe injury and having shone in Test cricket last winter, can also hold a bat. Advertisement More predictable was an instant return for Jacob Bethell, who missed the one-off Zimbabwe Test due to its clash with the Indian Premier League. With the 21-year-old all-rounder having shone during his maiden series in New Zealand last winter, the question now is whether he slots into the XI at the earliest opportunity. England squad for first Test Ben Stokes (c), Shoaib Bashir, Jacob Bethell, Harry Brook, Brydon Carse, Sam Cook, Zak Crawley, Ben Duckett, Jamie Overton, Ollie Pope, Joe Root, Jamie Smith (wk), Josh Tongue, Chris Woakes Schedule 1st Test: England v India, 20-24 June 2025, Headingley, Leeds Advertisement 2nd Test: England v India, 2-6 July 2025, Edgbaston, Birmingham 3rd Test: England v India, 10-14 July 2025, Lord's, London 4th Test: England v India, 23-27 July 2025, Emirates Old Trafford, Manchester 5th Test: England v India, 31 July-4 August 2025, Kia Oval, London If so it would represent something of a U-turn from Ben Stokes. Irked by debate around the No 3 position, and having watched Ollie Pope deliver a sparkling 171 at Trent Bridge in Bethell's absence, Stokes chuntered about a 'media agenda' in his post-match press conference and threw his weight behind his vice-captain. More positive for Stokes in the aftermath of that game was his own return to bowling after hamstring surgery at the start of the year. As a result, an initial plan to turn out for the Lions has been dropped and Stokes, who tends to opt out of warm-up cricket on tour, will probably continue his preparations in training.
Bloomberg
2 hours ago
- Bloomberg
Ola Electric Founder Topped Up Collateral as Shares Tumbled
By and Saikat Das Save Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Bhavish Aggarwal, founder and chief executive officer of Ola Electric Mobility Ltd., paid about 200 million rupees ($2.3 million) in cash to top up collateral for borrowings against shares, according to people with knowledge of the matter, as the stock slid on poor sales.
